RecommendsApproves of CEO
- Work/Life Balance
- Career Opportunities
- Comp & Benefits
- Senior Management
Friendly environment, collaborations, unique technology, exciting developments
- Few opportunities for promotion or career growth in my department - Company is frequently restructuring - Infrequent communication with senior management regarding important issues that affect employees
Advice to Management
Something as simple as quarterly updates as to the companies standing, progress/achievements, and corporate plans wold be appreciated by employees. A short newletter would suffice, just to keep unity of outlook for the company between management and scientists.
Getting an Interview
Getting an Interview
- No OfferNegative ExperienceEasy Interview
I applied online. The process took a week. I interviewed at Ambit Biosciences.
I received an email from the hiring manager, we'll call her Babs. We spoke for about 30 minutes. The conversation was frank and comfortable. She asked questions about career goals, experience, and desired work environment. I also asked several questions that were answered clearly. It was, what I thought, a great phone interview. Babs said she would call me back in a few days after she discussed my interview with her team and HR. I was told I would most likely be invited for an in-person interview. It's been 6 weeks and I have not heard from Babs. This is not an unusual occurence. However, it is very rude and unprofessional not to follow up if you claim that is your intention.
Let us know if we're missing any workplace or industry recognition –
Ambit Biosciences is looking hard for therapies to treat hard-to-cure cancers. A biotechnology company, Ambit discovers and develops drug therapies designed to treat aggressive or relapsed cancers. Its lead candidate, quizartinib, is a kinase inhibitor developed to treat cases of acute myeloid leukemia, a rare blood cancer characterized by abnormal white blood cell growth. (Kinase is an enzyme involved in cell division other cellular functions.) The company is developing the therapy through a partnership with Astellas Pharma. Ambit also has similar candidates in ...